The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, pharmacokinetics (PK), pharmacodynamics (Pd), and antitumor activity in a phase 1b study evaluating anti-ErbB3 antibody KTN3379 in adults with advanced tumors alone and with targeted therapies.
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Research Funding - 3-V Biosciences; Abbvie; Aileron Therapeutics; ARMO BioSciences; AstraZeneca; Celgene; DelMar Pharmaceuticals; eFFECTOR Therapeutics; EMD Serono; Fujifilm; Genmab; GlaxoSmithKline; Hutchison MediPharma; Incyte; Kolltan Pharmaceuticals; MedImmune; Millennium; Novartis; Regeneron; Strategia Therapeutics; Vegenics
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - EMD Serono; Millennium; Sarah Cannon Research Institute
 
Todd Michael Bauer
No Relationships to Disclose
 
Patricia LoRusso
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Genentech; Novartis
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst); Immunogen (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tensha Therapeutics (Inst)
 
Joseph Francis McLaughlin
Consulting or Advisory Role - Adaptimmune
Travel, Accommodations, Expenses - Adaptimmune; Kolltan Pharmaceuticals
 
Theresa LaVallee
Employment - Kolltan Pharmaceuticals
Leadership - Kolltan Pharmaceuticals
Stock and Other Ownership Interests - AstraZeneca; Kolltan Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Kolltan Pharmaceuticals
 
Ronald Alan Peck
Employment - Bristol-Myers Squibb; Kolltan Pharmaceuticals
Leadership - Kolltan Pharmaceuticals
Stock and Other Ownership Interests - Bristol-Myers Squibb; Kolltan Pharmaceuticals
 
Joseph Paul Eder
Honoraria - Merck